Adenovirus expression of IL-1 and NF-kappaB inhibitors does not inhibit acute adenoviral-induced brain inflammation, but delays immune system-mediated elimination of transgene expression.

[1]  P. Lowenstein,et al.  Inflammation and adaptive immune responses to adenoviral vectors injected into the brain: peculiarities, mechanisms, and consequences , 2003, Gene Therapy.

[2]  P. Lowenstein,et al.  Progress and challenges in viral vector-mediated gene transfer to the brain. , 2002, Current opinion in molecular therapeutics.

[3]  N. Wong,et al.  Differential Activation of Innate Immune Responses by Adenovirus and Adeno-Associated Virus Vectors , 2002, Journal of Virology.

[4]  P. Lowenstein,et al.  Adenovirus Binding to the Coxsackievirus and Adenovirus Receptor or Integrins Is Not Required To Elicit Brain Inflammation but Is Necessary To Transduce Specific Neural Cell Types , 2002, Journal of Virology.

[5]  T. Libermann,et al.  Adenovirus vector-induced inflammation: capsid-dependent induction of the C-C chemokine RANTES requires NF-kappa B. , 2002, Human gene therapy.

[6]  Inder M Verma,et al.  NF-kappaB regulation in the immune system. , 2002, Nature reviews. Immunology.

[7]  M. Castro,et al.  Towards global and long-term neurological gene therapy: unexpected transgene dependent, high-level, and widespread distribution of HSV-1 thymidine kinase throughout the CNS. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  S. Kochanek,et al.  Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectors. , 2001, Human gene therapy.

[9]  M. Castro,et al.  Gene Transfer into Neural Cells In Vitro Using Adenoviral Vectors , 2000, Current protocols in neuroscience.

[10]  P. Lowenstein,et al.  Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  V. Perry,et al.  Interleukin-1β-Induced Changes in Blood–Brain Barrier Permeability, Apparent Diffusion Coefficient, and Cerebral Blood Volume in the Rat Brain: A Magnetic Resonance Study , 2000, The Journal of Neuroscience.

[12]  M. Feldmann,et al.  Adenoviral transgene delivery provides an approach to identifying important molecular processes in inflammation: evidence for heterogenecity in the requirement for NFκB in tumour necrosis factor production , 2000, Annals of the rheumatic diseases.

[13]  P. Lowenstein,et al.  Strong promoters are the key to highly efficient, noninflammatory and noncytotoxic adenoviral-mediated transgene delivery into the brain in vivo. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  S. Kochanek,et al.  Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic diseases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Wood,et al.  Humoral immune responses to adenovirus vectors in the brain , 2000, Journal of Neuroimmunology.

[16]  L. Jacobsson,et al.  Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome? , 2000, Annals of the rheumatic diseases.

[17]  J. Bailey,et al.  Tetracycline-regulated overexpression of glycosyltransferases in Chinese hamster ovary cells. , 1999, Biotechnology and bioengineering.

[18]  J. Mallet,et al.  Efficient gene transfer and long-term expression in neurons using a recombinant adenovirus with a neuron-specific promoter , 1999, Gene Therapy.

[19]  Charles R. Gerfen,et al.  Current Protocols In Neuroscience , 1999 .

[20]  T. Libermann,et al.  Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. , 1999, Human gene therapy.

[21]  J Bondeson,et al.  Selective regulation of cytokine induction by adenoviral gene transfer of IkappaBalpha into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-kappaB independent. , 1999, Journal of immunology.

[22]  P. Lowenstein,et al.  Interleukin-1 Mediates a Rapid Inflammatory Response After Injection of Adenoviral Vectors into the Brain , 1999, The Journal of Neuroscience.

[23]  F. Steinhäuslin,et al.  Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis. , 1998, Journal of immunology.

[24]  M. Kay,et al.  Inhibition of NF-κB Activation in Combination with Bcl-2 Expression Allows for Persistence of First-Generation Adenovirus Vectors in the Mouse Liver , 1998, Journal of Virology.

[25]  R. Boltz,et al.  Characterization and quantitation of NF-kappaB nuclear translocation induced by interleukin-1 and tumor necrosis factor-alpha. Development and use of a high capacity fluorescence cytometric system. , 1998, The Journal of biological chemistry.

[26]  A. Mantovani,et al.  Regulation of Inhibitory Pathways of the Interleukin‐1 System , 1998, Annals of the New York Academy of Sciences.

[27]  S. Efstathiou,et al.  High adenoviral loads stimulate NFκB-dependent gene expression in human vascular smooth muscle cells , 1998, Gene Therapy.

[28]  S. Lightman,et al.  Long-term gene therapy in the CNS: Reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin , 1997, Nature Medicine.

[29]  G. Wilkinson,et al.  Cell type-specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors. , 1997, The Journal of general virology.

[30]  M. Wood,et al.  Role of T cells in inflammation caused by adenovirus vectors in the brain. , 1996, Gene therapy.

[31]  R. MacLaren,et al.  Immunological Instability of Persistent Adenovirus Vectors in the Brain: Peripheral Exposure to Vector Leads to Renewed Inflammation, Reduced Gene Expression, and Demyelination , 1996, The Journal of Neuroscience.

[32]  F. Bach,et al.  Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B , 1996, The Journal of experimental medicine.

[33]  D. O'Leary,et al.  Labeling Neural Cells Using Adenoviral Gene Transfer of Membrane-Targeted GFP , 1996, Neuron.

[34]  L. D. Dion,et al.  Supernatant rescue assay vs. polymerase chain reaction for detection of wild type adenovirus-contaminating recombinant adenovirus stocks. , 1996, Journal of virological methods.

[35]  M. Wood,et al.  Adenovirus gene transfer causes inflammation in the brain , 1995, Neuroscience.

[36]  J. Gustafsson,et al.  Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. , 1995, Molecular endocrinology.

[37]  B. Davidson,et al.  Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector. , 1995, Human gene therapy.

[38]  M. Cotten,et al.  Lipopolysaccharide is a frequent contaminant of plasmid DNA preparations and can be toxic to primary human cells in the presence of adenovirus. , 1994, Gene therapy.

[39]  Blake J. Roessler,et al.  A model system for in vivo gene transfer into the central nervous system using an adenoviral vector , 1993, Nature Genetics.

[40]  M. Perricaudet,et al.  An adenovirus vector for gene transfer into neurons and glia in the brain , 1993, Science.

[41]  M. Perricaudet,et al.  Transfer of a foreign gene into the brain using adenovirus vectors , 1993, Nature Genetics.

[42]  G. Wilkinson,et al.  Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. , 1992, Nucleic acids research.